- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04076995
INDIGO-2: The Effect of High Water Intake on Glucose Regulation in Low-drinkers (INDIGO-2)
February 7, 2020 updated by: Arizona State University
Previous studies have indicated increased vasopressin due to hypertonic saline infusion impairs glucose regulation.
The current study will examine the effect of low water intake on glucose regulation.
No currently published study has investigated the acute effect of low water intake on glucose regulation using continuous glucose monitoring over the course of a full day.
The aim of the study is to observe the effect of low water intake on glucose regulation in low drinkers.
The study will study the glycemic responses to standardized meals in adults during an 11-hour period in two conditions: a) high water intake and b) low water intake.
It is hypothesized that the area under the glucose curve will be greater in the low water intake trial as compared to the high water intake trial
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
7
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85004
- Arizona Biomedical Collaborative
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 55 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy sedentary participants
- aged 30-55 years
- body mass 27.5-35.0 kg·m2
- low water intake less than 1.5 L∙day-1 (male) or 1.0 L∙day-1 (female)
- 24 h urine osmolality greater than 800 mmol/kg
Exclusion Criteria:
- diabetes HbA1c >6.5%
- impaired liver or kidney function
- cardiovascular disease
- weight change of more than 3 kg in the past month
- pregnancy
- previous surgery on digestive tract
- exercise >4 h/week
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: High Water intake
High water intake of 3.0 L/day in males and 2.0 L/day in females
|
Increased water intake during the 11 h protocol
|
|
ACTIVE_COMPARATOR: Low Water Intake
Low water intake of 0.5 L/day in males and 0.4 L/day
|
Increased water intake during the 11 h protocol
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Area under the curve of Glucose at lunch
Time Frame: 2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
|
2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
|
|
Area under the curve of Glucose at Dinner
Time Frame: 2-hour window starting right before dinner (4:00 pm - 6:00 pm)
|
2-hour window starting right before dinner (4:00 pm - 6:00 pm)
|
|
Area under the curve of Glucose for the entire experiment
Time Frame: 11-hour window starting right before breakfast till 2 hours after dinner (7:00 am - 6:00 pm)
|
11-hour window starting right before breakfast till 2 hours after dinner (7:00 am - 6:00 pm)
|
|
Area under the curve of Copeptin for the entire experiment
Time Frame: 11-hour window starting right before breakfast till 2 hours after dinner (7:00 am - 6:00 pm)
|
11-hour window starting right before breakfast till 2 hours after dinner (7:00 am - 6:00 pm)
|
|
Area under the curve of Glucagon at lunch
Time Frame: 2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
|
2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
|
|
Area under the curve of Glucagon at dinner
Time Frame: 2-hour window starting right before dinner (4:00 pm - 6:00 pm)
|
2-hour window starting right before dinner (4:00 pm - 6:00 pm)
|
|
Urinary glucose excretion
Time Frame: Entire 11-hour protocol 7:00 am - 6:00 pm
|
Entire 11-hour protocol 7:00 am - 6:00 pm
|
|
Area Under the Curve for Plasma osmolality
Time Frame: the entire 11-hour protocol 7:00 am - 6:00 pm
|
the entire 11-hour protocol 7:00 am - 6:00 pm
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Area under the curve of Insulin at lunch
Time Frame: 2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
|
2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
|
|
|
Area under the curve of Insulin at dinner
Time Frame: 2-hour window starting right before dinner (4:00 pm - 6:00 pm)
|
2-hour window starting right before dinner (4:00 pm - 6:00 pm)
|
|
|
Area under the curve of Glucagon like peptide 1 at dinner
Time Frame: 2-hour window starting right before dinner (4:00 pm - 6:00 pm)
|
2-hour window starting right before dinner (4:00 pm - 6:00 pm)
|
|
|
Area under the curve of Glucagon like peptide 1at lunch
Time Frame: 2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
|
2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
|
|
|
Area under the curve of plasma cortisol
Time Frame: the entire 11-hour protocol 7:00 am - 6:00 pm
|
the entire 11-hour protocol 7:00 am - 6:00 pm
|
|
|
Area under the curve for Thirst rating
Time Frame: the entire 11-hour protocol 7:00 am - 6:00 pm
|
Thirst assessed by Visual analog scale
|
the entire 11-hour protocol 7:00 am - 6:00 pm
|
|
Mood assessment with a questionnaire
Time Frame: single measurement at baseline before the beginning of breakfast at 7:00 am and 1-hour before dinner meal at 3:00 pm
|
Assessed by Profile of mood state questionnaire
|
single measurement at baseline before the beginning of breakfast at 7:00 am and 1-hour before dinner meal at 3:00 pm
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 18, 2019
Primary Completion (ACTUAL)
December 19, 2019
Study Completion (ACTUAL)
December 19, 2019
Study Registration Dates
First Submitted
August 27, 2019
First Submitted That Met QC Criteria
August 30, 2019
First Posted (ACTUAL)
September 4, 2019
Study Record Updates
Last Update Posted (ACTUAL)
February 11, 2020
Last Update Submitted That Met QC Criteria
February 7, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00010276
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
ENBIOSIS BIOTECHNOLOGIESAydin Adnan Menderes University; Izmir University of Economics; Buca Seyfi Demirsoy... and other collaboratorsRecruitingType 2 Diabetes | Diabetes Mellitus Type 2Turkey (Türkiye)
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...Active, not recruiting
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes Mellitus | Type 2 Diabetes | Type2diabetes
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Kaiser PermanenteThe Permanente Medical GroupEnrolling by invitationType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2D)United States
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Steno Diabetes Center CopenhagenRecruitingDiabetes | Cognitive Impairment | Type 2 Diabetes | Diabetes Mellitus Type 2 | Cognitive Decline | Type 2 Diabetes Mellitus (T2DM)Denmark
Clinical Trials on Water Intake
-
Hospital de Clinicas de Porto AlegreActive, not recruitingRenal Function DisorderBrazil
-
ThinkWellWithdrawn
-
University of Illinois at Urbana-ChampaignDivision of Nutritional Sciences, University of Illinois at Urbana-ChampaignCompletedCognitive Change | Dehydration | Gastrointestinal MicrobiotaUnited States
-
Loughborough UniversityCompletedHypohydrated | EuhydratedUnited Kingdom
-
George Mason UniversityCompletedHydration and Resting Metabolism
-
California Polytechnic State University-San Luis...Enrolling by invitationBlood Glucose Concentration | Blood Glucose Self MonitoringUnited States
-
University of Illinois at Urbana-ChampaignDanone ResearchCompletedLow Fluid Intake, ChronicUnited States
-
The Rogosin InstituteWeill Medical College of Cornell UniversityCompletedAutosomal Dominant Polycystic KidneyUnited States
-
University Medical Centre LjubljanaCompletedAdolescent | Children | Hydration | Primary Headaches (Includes Migraines, Tension, Cluster Headaches)Slovenia